The effects of the endogenous, platelet-derived vasoactive compounds,
diadenosine tetraphosphate (AP(4)A), diadenosine pentaphosphate (AP(5)
A), and diadenosine hexaphosphate (AP(6)A) on the vasoconstriction of
isolated rat renal resistance vessels and rat aortic strips were measu
red using a vessel myograph. In addition, the effects of AP(4)A, AP(5)
A, and AP(6)A on the cytosolic free calcium concentration ([Ca2+](i))
were evaluated in cultured rat vascular smooth muscle cells (VSMC) usi
ng the fluorescent dye technique. Diadenosine polyphosphates dose-depe
ndently increased the force of renal resistance vessels and isolated a
ortic ships. The administration of 10 mu mol/L AP(4)A, AP(5)A, or AP(6
)A significantly increased the force of isolated renal resistance vess
els by 3.48 +/- 0.43 mN (n = 8), 2.14 +/- 0.40 mN (n = 12), or 2.70 +/
- 0.31 mN (n = 11, each P < .02 compared with resting tension), respec
tively. The administration of 10 mu mol/L AP(4)A, AP(5)A, or AP(6)A si
gnificantly increased the force of isolated aortic strips by 2.45 +/-
0.97 mNewton (n = 10), 2.70 +/- 0.30 mN (n = 6), or 1.48 +/- 0.20 mN (
each P < .01 compared with resting tension), respectively. The adminis
tration of 10 mu mol/L AP(4)A, AP(5)A, or AP(6)A significantly increas
ed [Ca2+](i) in VSMC to a peak concentration of 314 +/- 60 nmol/L (n =
6), 247 +/- 25 nmol/L (n = 15), or 332 +/- 100 nmol/L (n = 5), respec
tively (each P < .01 compared with resting value). Both the diadenosin
e polyphosphate-induced vasoconstriction and [Ca2+](i) increase was si
gnificantly reduced in the absence of extracellular calcium or after a
dministration of a specific inhibitor of P2 purinoceptors. It is concl
uded that diadenosine polyphosphates increase [Ca2+](i) and hence caus
e vessel constriction. (C) 1997 American Journal of Hypertension, Ltd.